Literature DB >> 16798934

Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.

G Troncone1, A Iaccarino, M Russo, E A Palmieri, M Volante, M Papotti, G Viglietto, L Palombini.   

Abstract

BACKGROUND: The down regulation of protein p27(kip1) (p27) in most cases of thyroid cancer has relevant diagnostic and prognostic implications. However, the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma expresses more p27 than benign oxyphilic lesions do. AIM: To evaluate the mechanism underlying this difference in expression of p27.
METHODS: Because high levels of cyclin D3 lead to p27 accumulation in cell lines and clinical samples of thyroid cancer, the immunocytochemical pattern of cyclin D3 in oxyphilic (n = 47) and non-oxyphilic (n = 70) thyroid neoplasms was investigated.
RESULTS: In the whole study sample, there was a significant correlation between p27 and cyclin D3 expression (Spearman's r: 0.64; p<0.001). The expression of cyclin D3 and p27 was significantly higher in the oxyphilic variant of follicular carcinomas than in non-oxyphilic carcinomas (p<0.001). In the former, cyclin D3 overexpression and p27 accumulation were observed in a median of 75% and 55% of cells, respectively. In co-immunoprecipitation experiments, the level of p27-bound cyclin D3 was much higher in oxyphilic neoplasias than in normal thyroids and other thyroid tumours.
CONCLUSION: These results show that increased p27 expression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma results from cyclin D3 overexpression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798934      PMCID: PMC2001124          DOI: 10.1136/jcp.2005.036012

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

Authors:  M Sánchez-Beato; F I Camacho; J C Martínez-Montero; A I Sáez; R Villuendas; L Sánchez-Verde; J F García; M A Piris
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

3.  Cyclin-dependent kinase inhibitor p27(Kip1) expression in thyroid cells obtained by fine-needle aspiration biopsy: a preliminary report.

Authors:  G Troncone; F Fulciniti; P Zeppa; A Vetrani; A Caleo; L Palombini
Journal:  Diagn Cytopathol       Date:  2000-08       Impact factor: 1.582

4.  Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease.

Authors:  Mark L C Khoo; Jeremy L Freeman; Ian J Witterick; Jonathan C Irish; Lorne E Rotstein; Patrick J Gullane; Sylvia L Asa
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-03

5.  Preparation of peroxidase: antiperoxidase (PAP) complexes for immunohistological labeling of monoclonal antibodies.

Authors:  D Y Mason; J L Cordell; Z Abdulaziz; M Naiem; G Bordenave
Journal:  J Histochem Cytochem       Date:  1982-11       Impact factor: 2.479

6.  Cyclin D3 immunoreactivity is an independent predictor of survival in laryngeal squamous cell carcinoma.

Authors:  Giancarlo Pruneri; Lorenzo Pignataro; Stefano Valentini; Sonia Fabris; Patrick Maisonneuve; Nadia Carboni; Salvatore Pece; Maria Capra; Barbara Del Curto; Antonino Neri; Giuseppe Viale
Journal:  Clin Cancer Res       Date:  2005-01-01       Impact factor: 12.531

7.  Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.

Authors:  L A Erickson; L Jin; P C Wollan; G B Thompson; J van Heerden; R V Lloyd
Journal:  Mod Pathol       Date:  1998-02       Impact factor: 7.842

8.  Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells.

Authors:  G Baldassarre; B Belletti; P Bruni; A Boccia; F Trapasso; F Pentimalli; M V Barone; G Chiappetta; M T Vento; S Spiezia; A Fusco; G Viglietto
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

9.  Cyclin D3 expression in normal, reactive and neoplastic tissues.

Authors:  C Doglioni; C Chiarelli; E Macrí; A P Dei Tos; E Meggiolaro; P Dalla Palma; M Barbareschi
Journal:  J Pathol       Date:  1998-06       Impact factor: 7.996

10.  The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis.

Authors:  S Wang; J Wuu; L Savas; N Patwardhan; A Khan
Journal:  Hum Pathol       Date:  1998-11       Impact factor: 3.466

View more
  3 in total

Review 1.  Oncocytic mania: a review of oncocytic lesions throughout the body.

Authors:  F Guaraldi; G Zang; A P Dackiw; P Caturegli
Journal:  J Endocrinol Invest       Date:  2011-02-07       Impact factor: 4.256

Review 2.  Prognostic significance of cyclin D3 expression in malignancy patients: a meta-analysis.

Authors:  Bo Wang; Zijian Wang; Lizhi Han; Song Gong; Yanxue Wang; Zhiwen He; Yong Feng; Zhaohui Yang
Journal:  Cancer Cell Int       Date:  2019-06-10       Impact factor: 5.722

3.  Galectin-3 and Cyclin D3 Immunohistochemistry and Tumor Dimensions Are Useful in Distinguishing Follicular Oncocytic Carcinomas from Oncocytic Adenomas of the Thyroid.

Authors:  C Cacchi; H M Arnholdt; C J Haas; H Kretsinger; L Axt; B Märkl
Journal:  Int J Endocrinol       Date:  2015-10-29       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.